Search Results 91-100 of 15205 for Inhibition
In Part 1, 12 subjects with relapsed or refractory malignant mesothelioma regardless of BAP1 status will be treated and undergo pharmacokinetics (PK) blood ...
Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) · Overview · Participation ...
Ceritinib, an inhibitor of multiple protein kinases, has approval from the U.S. Food and Drug Administration (FDA) to treat ALK gene rearrangement-positive non- ...
Renin-angiotensin system inhibition in the treatment of hypertension. https://www.uptodate.com/contents/search. Accessed March 17, 2023. Bakris GL ...
About this study. This project will be a pilot study aiming to describe the change of skin quality after initiation of Aromatase Inhibitor therapy in Breast ...
The Mukhopadhyay Tumor Angiogenesis and Vascular Biology Lab at Mayo Clinic is developing inhibitory peptides and small molecules to target GIPC and its ...
The purpose of this phase Ib trial studies the side effects of MDM2 inhibitor AMG-232 and radiation therapy in treating patients with soft tissue sarcoma. MDM2 ...
RATIONALE: Aurora A kinase inhibitor MLN8237 and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. PURPOSE: ...
The purpose of this post-marketing study is to compare the safety of tofacitinib versus tumor necrosis factor inhibitor with respect to major cardiovascular ...
A Study to Evaluate Sex Disparities in Arthrogenic Muscle Inhibition Rochester, MN. Incidence of anterior cruciate ligament (ACL) ruptures ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.